Liquid Biosciences

Liquid Biosciences operates as a bio-analytics and precision medicine services company, utilizing a sophisticated computational platform to analyze multi-omics data across more than 60 diseases. With over 300 completed projects for 35 major biopharma, diagnostic, and academic clients, the company has a track record of biomarker discovery and drug development support. The leadership team possesses deep, long-standing expertise in biotech, software engineering, and high-performance computing, positioning the firm as a specialized partner in a data-driven healthcare era.

Proprietary bio-analytics platform integrating multi-omics and clinical data using advanced algorithms beyond conventional AI for biomarker discovery and drug development insights.

Liquid Biosciences competes in the bioinformatics and precision medicine analytics space against specialized AI-driven biotech startups (e.g., Tempus, Recursion), large contract research organizations (e.g., IQVIA, LabCorp), and the data science divisions of large tech companies. Its differentiation lies in its proprietary algorithms, extensive project history, and deeply experienced, long-tenured leadership team.